.jpg?format=webp&width=780)
Alveolar capillary dysplasia (ACD) is a rare lung disorder that affects neonates and can lead to severe pulmonary hypertension. A recent study found a potential treatment for ACD by screening a library of compounds and identifying TanFe as the most effective candidate. TanFe stabilizes the FOXF1 protein expression, which leads to increased expression of downstream FOXF1 target genes, decreased endothelial permeability, and inhibited lung inflammation. TanFe also improved angiogenesis in vascular organoids derived from induced pluripotent stem cells from a human patient with ACD. Prenatal treatment of pregnant mice with TanFe rescued the phenotype in affected offspring. TanFe may also represent a novel strategy to enhance pulmonary vascular development and augment postnatal alveolarization for other neonatal lung diseases.
Like
Save
Share